Fibroblast growth factor 21 inhibited ischemic arrhythmias via targeting miR-143/EGR1 axis
Fibroblast growth factor 21 inhibited ischemic arrhythmias via targeting miR-143/EGR1 axis
复制标题
成纤维细胞生长因子 21 通过靶向 miR-143/EGR1 轴抑制缺血性心律失常。
DOI:
10.1007/s00395-019-0768-4
复制
发表时间:
2020-01-04
影响因子:
9.5
通讯作者:
Yang, Baofeng
中科院分区:
文献类型:
--
作者:
Li, Jiamin;Xu, Chaoqian;Yang, Baofeng
Ventricular arrhythmia is the most common cause of sudden cardiac death in patients with myocardial infarction (MI). Fibroblast growth factor 21 (FGF21) has been shown to play an important role in cardiovascular and metabolic diseases. However, the effects of FGF21 on ventricular arrhythmias following MI have not been addressed yet. The present study was conducted to investigate the pharmacological action of FGF21 on ventricular arrhythmias after MI. Adult male mice were administrated with or without recombinant human basic FGF21 (rhbFGF21), and the susceptibility to arrhythmias was assessed by programmed electrical stimulation and optical mapping techniques. Here, we found that rhbFGF21 administration reduced the occurrence of ventricular tachycardia (VT), improved epicardial conduction velocity and shorted action potential duration at 90% (APD90) in infarcted mouse hearts. Mechanistically, FGF21 may improve cardiac electrophysiological remodeling as characterized by the decrease ofINaandIK1current density in border zone of infarcted mouse hearts. Consistently, in vitro study also demonstrated that FGF21 may rescue oxidant stress-induced dysfunction ofINaandIK1currents in cultured ventricular myocytes. We further found that oxidant stress-induced down-regulation of early growth response protein 1 (EGR1) contributed toINaandIK1reduction in post-infarcted hearts, and FGF21 may recruit EGR1 into theSCN5AandKCNJ2promoter regions to up-regulate NaV1.5 and Kir2.1 expression at transcriptional level. Moreover, miR-143 was identified as upstream of EGR1 and mediated FGF21-induced EGR1 up-regulation in cardiomyocytes. Collectively, rhbFGF21 administration effectively suppressed ventricular arrhythmias in post-infarcted hearts by regulating miR-143-EGR1-NaV1.5/Kir2.1 axis, which provides novel therapeutic strategies for ischemic arrhythmias in clinics.